These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Imaging in inflammatory arthritis: progress towards precision medicine. Minopoulou I; Kleyer A; Yalcin-Mutlu M; Fagni F; Kemenes S; Schmidkonz C; Atzinger A; Pachowsky M; Engel K; Folle L; Roemer F; Waldner M; D'Agostino MA; Schett G; Simon D Nat Rev Rheumatol; 2023 Oct; 19(10):650-665. PubMed ID: 37684361 [TBL] [Abstract][Full Text] [Related]
3. A cross-scanner and cross-tracer deep learning method for the recovery of standard-dose imaging quality from low-dose PET. Xue S; Guo R; Bohn KP; Matzke J; Viscione M; Alberts I; Meng H; Sun C; Zhang M; Zhang M; Sznitman R; El Fakhri G; Rominger A; Li B; Shi K Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1843-1856. PubMed ID: 34950968 [TBL] [Abstract][Full Text] [Related]
4. Gd(III)-Gold Nanoconjugates Provide Remarkable Cell Labeling for High Field Magnetic Resonance Imaging. Rammohan N; Holbrook RJ; Rotz MW; MacRenaris KW; Preslar AT; Carney CE; Reichova V; Meade TJ Bioconjug Chem; 2017 Jan; 28(1):153-160. PubMed ID: 27537821 [TBL] [Abstract][Full Text] [Related]
5. Combined PET/MRI: from Status Quo to Status Go. Summary Report of the Fifth International Workshop on PET/MR Imaging; February 15-19, 2016; Tübingen, Germany. Bailey DL; Pichler BJ; Gückel B; Barthel H; Beer AJ; Botnar R; Gillies R; Goh V; Gotthardt M; Hicks RJ; Lanzenberger R; la Fougere C; Lentschig M; Nekolla SG; Niederdraenk T; Nikolaou K; Nuyts J; Olego D; Riklund KÅ; Signore A; Schäfers M; Sossi V; Suminski M; Veit-Haibach P; Umutlu L; Wissmeyer M; Beyer T Mol Imaging Biol; 2016 Oct; 18(5):637-50. PubMed ID: 27534971 [TBL] [Abstract][Full Text] [Related]
6. Biomarkers to guide clinical therapeutics in rheumatology? Robinson WH; Mao R Curr Opin Rheumatol; 2016 Mar; 28(2):168-75. PubMed ID: 26720904 [TBL] [Abstract][Full Text] [Related]
7. Semi-quantitative analysis of Ravikanth R; Singh JK World J Nucl Med; 2020; 19(4):347-352. PubMed ID: 33623503 [No Abstract] [Full Text] [Related]
8. Clinical utility of F-18 sodium fluoride PET/CT for estimating disease activity in patients with rheumatoid arthritis. Park HJ; Chang SH; Lee JW; Lee SM Quant Imaging Med Surg; 2021 Apr; 11(4):1156-1169. PubMed ID: 33816157 [TBL] [Abstract][Full Text] [Related]
10. Plaque Thrombosis is Reduced by Attenuating Plaque Inflammation with Pioglitazone and is Evaluated by Fluorodeoxyglucose Positron Emission Tomography. Zhang MD; Zhao XC; Zhang YH; Yan YF; Wang ZM; Lv SZ; Zhao QM Cardiovasc Ther; 2015 Jun; 33(3):118-26. PubMed ID: 25825053 [TBL] [Abstract][Full Text] [Related]
11. Imaging atherosclerosis in rheumatoid arthritis: evidence for increased prevalence, altered phenotype and a link between systemic and localised plaque inflammation. Skeoch S; Cristinacce PLH; Williams H; Pemberton P; Xu D; Sun J; James J; Yuan C; Hatsukami T; Hockings PD; Alexander MY; Waterton JC; Bruce IN Sci Rep; 2017 Apr; 7(1):827. PubMed ID: 28400572 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of carotid plaque inflammation in patients with active rheumatoid arthritis using (18)F-fluorodeoxyglucose PET-CT and MRI: a pilot study. Skeoch S; Williams H; Cristinacce P; Hockings P; James J; Alexander Y; Waterton J; Bruce I Lancet; 2015 Feb; 385 Suppl 1():S91. PubMed ID: 26312914 [TBL] [Abstract][Full Text] [Related]